Skip to main content

Cracking Down on Cancer: A Profile of Owen Witte

Through his studies on cancer-causing viruses, the University of California, Los Angeles, professor has helped develop lifesaving treatments.

Written byDiana Kwon
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00

ABOVE: Acute lymphoblastic leukemia blood smear
© ISTOCK.COM, JXFZSY

Sitting at a lab bench at MIT in the late 1970s, Owen Witte finally had to admit he was stuck. He had identified a cancer-causing protein encoded in the genome of the Abelson murine leukemia virus, which infects mice. Prior work had led Witte to hypothesize that this protein should be a kinase, an enzyme that attaches phosphoryl groups to amino acids. But after double- and triple-checking his methods and repeating the experiments several times, he failed to find evidence that this was the case.

Witte’s idea that the Abelson murine leukemia virus (A-MuLV) protein should be a protein kinase stemmed primarily from work by molecular biologist Raymond Erikson, then at the University of Colorado, and his colleagues. They had shown that the oncogenic viral gene src was associated with protein kinases, and Witte expected to find something similar with A-MuLV. He ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile

Related Topics

Published In

April 2020

Exercise for Cancer

Molecular clues link physical activity to improved patient outcomes

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo